AKT1 and neuroendocrine neoplasm: To clarify the molecular mechanisms underlying the synergistic anti-tumor effects of Sulfatinib and Kaempferol, a study was undertaken to assess their impact on the PI3K/AKT/mTOR signaling pathway within neuroendocrine tumor cells.